Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou, 310058, Zhejiang, People's Republic of China.
Beijing Ming-tian Genetics Ltd., Beijing, 100070, People's Republic of China.
Genome Biol. 2018 Oct 17;19(1):163. doi: 10.1186/s13059-018-1553-7.
Current single-cell RNA-seq approaches are hindered by preamplification bias, loss of strand of origin information, and the inability to observe small-RNA and mRNA dual transcriptomes. Here, we introduce a single-cell holo-transcriptome sequencing (Holo-Seq) that overcomes all three hurdles. Holo-Seq has the same quantitative accuracy and uniform coverage with a complete strand of origin information as bulk RNA-seq. Most importantly, Holo-Seq can simultaneously observe small RNAs and mRNAs in a single cell. Furthermore, we acquire small RNA and mRNA dual transcriptomes of 32 human hepatocellular carcinoma single cells, which display the genome-wide super-enhancer activity and hepatic neoplasm kinetics of these cells.
目前的单细胞 RNA 测序方法受到预扩增偏差、原始链信息丢失以及无法观察小 RNA 和 mRNA 双重转录组的限制。在这里,我们介绍了一种克服这三个障碍的单细胞全转录组测序(Holo-Seq)。Holo-Seq 与批量 RNA-seq 具有相同的定量准确性和均匀覆盖度,并且保留了完整的原始链信息。最重要的是,Holo-Seq 可以在单个细胞中同时观察小 RNA 和 mRNA。此外,我们还获得了 32 个人肝癌单细胞的小 RNA 和 mRNA 双重转录组,这些转录组显示了这些细胞的全基因组超级增强子活性和肝肿瘤动力学。